Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Syneos Health Inc.
Headquarters: Morrisville, NC, United States of America
Website: https://www.syneoshealth.com/...
Year Founded: 1985
Status: Private
BioCentury | Oct 29, 2024
Management Tracks
Biogen names new CFO, CMO
Plus management updates at Ottimo, Genascence, Pll, Nabsys 2.0 and Arbutus
BioCentury | Oct 11, 2024
Management Tracks
Flagship takes on a third managing partner
Plus: New CEOs at Wheeler, Abalos, Oncovita, Syneos and Calluna, and updates from Phase, Ziphius and more
BioCentury | Oct 3, 2023
Management Tracks
Affibody names Peter Zerhouni CFO
Plus: Restructuring at Kezar as CEO, CMO step down, and updates from Atomwise, Aura, Twist, Acelyrin and more
BioCentury | Sep 27, 2023
Management Tracks
Morphic CEO Tipirneni taking medical leave of absence
Plus: David Stack to retire as chair, CEO of Pacira and updates from AM-Pharma, Invitae, Syneos and Faeth
BioCentury | May 10, 2023
Deals
May 10 Quick Takes: Bicycle in third radiopharma deal of year
Plus: 15% weight reduction for Boehringer, Zealand Phase II asset and updates from Aviko, DiogenX, Syneos, OliX and more
BioCentury | Apr 27, 2023
Management Tracks
BMS’s Caforio to retire as CEO
Plus: Rectify hires Minegishi and updates from Epsilogen, Novo and more
BioCentury | Sep 12, 2022
Management Tracks
Biden names Wegrzyn to lead ARPA-H
Plus bluebird’s Cole resigns as CFO, and updates from Cellics, Scorpion, Day One and more
BioCentury | Jul 14, 2022
Management Tracks
Cantrell joins Brii as CBO
Plus Chan Lee to be general counsel at BeiGene and updates from CytoDyn, Kezar, Anaveon, Fulcrum and more
BioCentury | Sep 1, 2021
Regulation
A role for RWE in the accelerated approval pathway
Real-world evidence is poised to make its mark on confirmatory trials
BioCentury | Apr 16, 2021
Deals
PPD’s acquisition history: Data Byte
Thermo Fisher’s $17.4 billion buyout of PPD brings the CRO’s 36-year run to a close. On Thursday, Thermo Fisher Scientific Inc. (NYSE:TMO) announced plans to acquire PPD Inc.
Items per page:
1 - 10 of 16